News & Updates

Original New Drug Application Approvals by US FDA (16 - 31 July 2022)

31 Jul 2022

New drug applications approved by US FDA as of 16 - 31 July 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 July 2022)

31 Jul 2022

Pembro + chemo prolongs OS in TNBC patients with high PD-L1 expression

30 Jul 2022 by

Adding pembrolizumab to chemotherapy in the first-line setting significantly prolongs overall survival (OS) in patients with triple-negative breast cancer (TNBC) whose tumours expressed programmed death-ligand 1 (PD-L1) with a CPS* of ≥10, compared with chemotherapy alone, according to the KEYNOTE-355** trial.

Pembro + chemo prolongs OS in TNBC patients with high PD-L1 expression

30 Jul 2022

COVID-19 shots temporarily mess up menstrual cycle length

29 Jul 2022 by

Women who receive COVID-19 jabs may experience short-term changes in their menstrual cycle length, particularly those who have short, long, or irregular cycles prior to vaccination, a study has found.

COVID-19 shots temporarily mess up menstrual cycle length

29 Jul 2022

Which drugs raise risk of urinary tract infections?

29 Jul 2022 by

Some medications may directly cause the occurrence of urinary tract infections (UTIs), and a recent study presented at the 37th Annual European Association of Urology Congress (EAU 2022) has identified six drugs that appear to contribute to “significant reporting levels” for infections.

Which drugs raise risk of urinary tract infections?

29 Jul 2022

Polypharmacy, steep out-of-pocket costs hound cancer patients at end of life

29 Jul 2022

Polypharmacy frequently occurs in most patients with advanced cancer at end of life, reports a recent study. However, most medications used are usually for supportive care.

Polypharmacy, steep out-of-pocket costs hound cancer patients at end of life

29 Jul 2022

BTX relieves endometriosis-associated chronic pelvic pain

29 Jul 2022 by

The administration of onabotulinumtoxinA (BTX) led to relief of pain and spasm in premenopausal women with persistent pelvic pain due to endometriosis, a study presented at ESHRE 2022 has shown.

BTX relieves endometriosis-associated chronic pelvic pain

29 Jul 2022

Glucose-lowering medications protect against glaucoma, AMD

29 Jul 2022

While diabetes is a risk factor for cataract, glucose-lowering medications appear to have a protective effect on the risks of open-angle glaucoma (OAG) and age-related macular degeneration (AMD), as shown in a study.

Glucose-lowering medications protect against glaucoma, AMD

29 Jul 2022

Verapamil reduces penile curvature, plaque size in Peyronie’s disease

28 Jul 2022 by

Use of the calcium channel blocker verapamil is both safe and effective for the treatment of Peyronie’s disease, as proven by a decrease in penile curvature, reduction in plaque size, and improvement in erectile dysfunction, with minimal to mild side effects, relative to placebo, according to the results of a systematic review and meta-analysis.